Cortexyme Raises $1M

Cortexyme, a San Francisco CA-based healthcare technology company, raised $1m in funding.

The round was led by evergreen fund Dolby Family Ventures, which invested $500k.

The company intends to use the funds to continue preclinical research.

Led by Casey Lynch, CEO, Cortexyme is developing novel therapeutics and diagnostics for Alzheimer’s disease and other neurodegenerative disorders.



Join the discussion